Patents by Inventor Michael Sturek

Michael Sturek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9414901
    Abstract: Drug eluting stents (DES) useful for the treatment of restenosis are described. The stents comprise biocompatible polymers and adenosine receptor modulators.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: August 16, 2016
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Michael Sturek, Kinam Park
  • Publication number: 20130158383
    Abstract: An imaging system, including a radiation source configured to output a signal that can non-invasively and selectively cause overtone excitation of molecules based on a predetermined chemical bond, and an ultrasound detector configured to non-invasively detect an acoustic signal generated by vibrational energy caused by the selective overtone excitation of the molecules and further configured to convert the acoustic signal into an image.
    Type: Application
    Filed: August 22, 2011
    Publication date: June 20, 2013
    Applicant: PURDUE RESEARCH FOUNDATION
    Inventors: Ji-Xin Cheng, Han-Wei Wang, Michael Sturek
  • Publication number: 20110189255
    Abstract: Drug eluting stents (DES) useful for the treatment of restenosis are described. The stents comprise biocompatible polymers and adenosine receptor modulators.
    Type: Application
    Filed: October 1, 2010
    Publication date: August 4, 2011
    Inventors: Michael STUREK, Kinam PARK
  • Publication number: 20050074448
    Abstract: Endothelial cells produce many factors that are involved in maintaining blood vessels. One of the best understood and most studied factor is nitric oxide (NO), which is produced by an endothelial enzyme called nitric oxide synthase (eNOS). The present invention provides a molecule designed to be delivered to the endothelium where it can reconstitute eNOS activity and restore NO production. Thus, the present invention provides methods of detecting, treating and preventing diseases or disorders associated with the vasculature and denoted by reduced levels of eNOS in the endothelium, as well as a concomitant reduction in the amount of NO that can be produced.
    Type: Application
    Filed: March 24, 2004
    Publication date: April 7, 2005
    Inventors: Elmer Price, Harold Laughlin, Chris Woodman, Miles Tanner, Michael Sturek